You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I’m a 73-year-old male in good health. I’m starting to show ...

Objective: The objective of this study was todirectly assess the likelihood and timing of alphablocker discontinuation in patients receivingcombination therapy with dutasteride orfinasteride plus an ...

About 9,000 alpha-blocker patients had a fracture versus 3,351 matched patients on other antihypertensives; “9,000 patients out of 70,000 is a huge number. These drugs are useful in some situations, ...

A meta-analysis evaluated the efficacy and safety of imidafenacin for overactive bladder induced by benign prostatic hyperplasia. Combining imidafenacin with an alpha-blocker may effectively treat ...

: To evaluate the likelihood of alphaadrenergic antagonist (alpha-blocker) discontinuation in combination with dutasteride or finasteride among patients aged =65 years with enlarged prostate. Methods ...

ischemic stroke Investigators found an increased risk of ischemic stroke among all patients within 21 days following initiation of alpha-blocker therapy. Men who have recently begun alpha-blocker ...

The Prostate Cancer Prevention Trial has shown a protective effect of finasteride on prostate cancer in low-risk men. It is uncertain whether similar results can be expected when finasteride is used ...

New findings show that treatment with a specific alpha blocker helps reduce symptoms and improve quality of life for men with chronic prostatitis/chronic pelvic pain syndrome. Subscribe today for ...

Rapaflo (silodosin), an alpha blocker marketed by Watson Pharmaceuticals, Inc., in Corona, Calif., for oral, once-daily treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) has ...

DEAR DR. ROACH: I’m a 73-year-old male in good health. I’m starting to show signs of prostate troubles. I have trouble starting to urinate, and the stream stops and starts, usually at night before bed ...